RA CAPITAL MANAGEMENT, L.P. sold 13.6% of their position (620.13K shares) of VOR BIOPHARMA INC. on the open market
Open‑market sale worth $10.23M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 4/10/2026ACC: 0001231919-26-000333
Director10% Owner
Since Feb 2021
-620.13K
Net shares
Net seller
$10.23M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
620.13K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−353.24K
Price / share
$16.32
Trade value
$5.76M
% of position
7.8%
4/8/2026
4.56M→4.20M
Common Stock
Indirect
Shares
−130.86K
Price / share
$16.91
Trade value
$2.21M
% of position
3.1%
4/8/2026
4.20M→4.07M
Common Stock
Indirect
Shares
−135.20K
Price / share
$16.59
Trade value
$2.24M
% of position
3.3%
4/9/2026
4.07M→3.94M
Common Stock
Indirect
Shares
−828.00
Price / share
$15.75
Trade value
$13.04K
% of position
0.0%
4/10/2026
3.94M→3.94M
Total
Net shares
−620.13K
Net value
-$10.23M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/8/2026 | S · Sale | −353.24K | $16.32 | $5.76M | 7.8% | 4.56M | 4.20M |
| Common Stock Indirect | 4/8/2026 | S · Sale | −130.86K | $16.91 | $2.21M | 3.1% | 4.20M | 4.07M |
| Common Stock Indirect | 4/9/2026 | S · Sale | −135.20K | $16.59 | $2.24M | 3.3% | 4.07M | 3.94M |
| Common Stock Indirect | 4/10/2026 | S · Sale | −828.00 | $15.75 | $13.04K | 0.0% | 3.94M | 3.94M |
| Total | −620.13K | -$10.23M | ||||||
Derivative Transactions0
No derivative transactions reported